Michael Dacks

Michael Dacks

Founder at Type 2 Ventures Ltd.

47 year
Process Industries
Consumer Services
Health Technology

Profile

Michael Dacks is the founder of Midatadin.com Ltd.
(founded in 2013) and Type 2 Ventures Ltd.
(founded in 2019).
He is currently the President & Chief Operating Officer at Psyence Therapeutics Corp.
(since 2020).
He previously held positions at Vertical Peak Holdings, Inc. as an Independent Director, MedReleaf Corp.
as VP-Legal & International Business Affair (2016-2018), Plena Global Holdings, Inc. as Senior Vice President-Global Affairs (2018-2019), StateHouse Holdings, Inc. as Director (2020-2021), and Psyence Group, Inc. as Chief Operating Officer (2020-2021).
Mr. Dacks received his undergraduate degree from the University of Western Ontario in 1998 and his graduate degree from Osgoode Hall Law School in 2004.

Michael Dacks active positions

CompaniesPositionStart
Type 2 Ventures Ltd. Founder 2019-03-31
Psyence Therapeutics Corp. President 2020-07-31
All active positions of Michael Dacks

Former positions of Michael Dacks

CompaniesPositionEnd
STATEHOUSE HOLDINGS INC. Director/Board Member 2021-12-30
PSYENCE GROUP INC. Chief Operating Officer 2021-01-31
Corporate Officer/Principal 2019-06-30
MEDRELEAF CORP General Counsel 2018-09-01
Midatadin.com Ltd. Founder 2016-06-30
See the detail of Michael Dacks's experience

Training of Michael Dacks

University of Western Ontario Undergraduate Degree
Osgoode Hall Law School Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Dacks's experience

Connections

100 +

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
VERTICAL PEAK HOLDINGS INC.

Process Industries

STATEHOUSE HOLDINGS INC.

Process Industries

PSYENCE GROUP INC.

Industrial Services

Private companies5

Health Technology

Process Industries

Midatadin.com Ltd.

Type 2 Ventures Ltd.

Psyence Therapeutics Corp.

See company connections